175 related articles for article (PubMed ID: 36195677)
1. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels.
Lui MS; Clemente-Gutierrez U; Vodopivec DM; Chang SL; Shirali AS; Huang BL; Chiang YJ; Fisher SB; Grubbs EG; Guise TA; Graham PH; Perrier ND
World J Surg; 2023 Feb; 47(2):363-370. PubMed ID: 36195677
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
[TBL] [Abstract][Full Text] [Related]
3. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
4. Normocalcemic Hyperparathyroidism.
Corbetta S
Front Horm Res; 2019; 51():23-39. PubMed ID: 30641527
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
[TBL] [Abstract][Full Text] [Related]
6. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.
Schini M; Jacques RM; Oakes E; Peel NFA; Walsh JS; Eastell R
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1171-86. PubMed ID: 32072184
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characteristics and clinical manifestation of normocalcemic primary hyperparathyroidism.
Yankova I; Lilova L; Petrova D; Dimitrova I; Stoynova M; Shinkov A; Kovatcheva R
Endocrine; 2024 Mar; ():. PubMed ID: 38489132
[TBL] [Abstract][Full Text] [Related]
8. Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.
Choi HR; Choi SH; Hong N; Rhee Y; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
J Korean Med Sci; 2022 Apr; 37(13):e99. PubMed ID: 35380024
[TBL] [Abstract][Full Text] [Related]
9. Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.
Chertok Shacham E; Maman N; Lazareva T; Masalha R; Mahagna L; Sela G; Ishay A
Front Endocrinol (Lausanne); 2023; 14():1152464. PubMed ID: 37065752
[TBL] [Abstract][Full Text] [Related]
10. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
Cesareo R; Di Stasio E; Vescini F; Campagna G; Cianni R; Pasqualini V; Romitelli F; Grimaldi F; Manfrini S; Palermo A
Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023
[TBL] [Abstract][Full Text] [Related]
11. Letter to the Editor: Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism (nPHPT) is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels.
Jagannath S; Mayilvaganan S; Idrees S
World J Surg; 2023 Mar; 47(3):829. PubMed ID: 36480058
[No Abstract] [Full Text] [Related]
12. Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database.
Keutgen XM; Buitrago D; Filicori F; Kundel A; Elemento O; Fahey TJ; Zarnegar R
Ann Surg; 2012 May; 255(5):981-5. PubMed ID: 22470074
[TBL] [Abstract][Full Text] [Related]
13. Normocalcemic primary hyperparathyroidism: long-term follow-up associated with multiple adenomas.
Pimentel L; Portela S; Loureiro A; Bandeira F
Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):583-6. PubMed ID: 25166050
[TBL] [Abstract][Full Text] [Related]
14. Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Payet J; Sarfati E; Borderie D; Kahan A; Cormier C
Osteoporos Int; 2014 Jul; 25(7):1963-8. PubMed ID: 24676846
[TBL] [Abstract][Full Text] [Related]
15. Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?
Aojula N; Khan S; Gittoes N; Hassan-Smith Z
Ther Adv Endocrinol Metab; 2021; 12():2042018821995370. PubMed ID: 33717430
[TBL] [Abstract][Full Text] [Related]
16. Does Baseline PTH Influence Recovery of Bone Mineral Density, Trabecular Bone Score and Bone Turnover Markers? A Prospective Study Following Curative PArathyroidectomy in Primary Hyperparathyroidism.
Shetty S; Cherian KE; Shetty S; Kapoor N; Jebasingh FK; Cherian A; Hephzibah J; Chandramohan A; John RA; Asha HS; Paul MJ; Manipadam MT; Abraham DT; Thomas N; Paul TV
Endocr Pract; 2020 Dec; 26(12):1442-1450. PubMed ID: 33471736
[TBL] [Abstract][Full Text] [Related]
17. Comparative utility of preoperative imaging in normocalcemic versus hypercalcemic primary hyperparathyroidism.
Montgomery KB; Gillis A; Ramonell KM; Fazendin JM; Lindeman B; Chen H
Am J Surg; 2023 Feb; 225(2):293-297. PubMed ID: 36175194
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Observation Versus Parathyroidectomy on Bone Mineral Density and Fracture Risk Determined by FRAX Tool in Patients With Primary Hyperparathyroidism.
Khan R; Martin J; Das G
J Clin Densitom; 2021; 24(4):571-580. PubMed ID: 33390308
[TBL] [Abstract][Full Text] [Related]
19. Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?
Traini E; Bellantone R; Tempera SE; Russo S; De Crea C; Lombardi CP; Raffaelli M
Langenbecks Arch Surg; 2018 May; 403(3):317-323. PubMed ID: 29541851
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Thoracic Muscle Mass Predicts Bone Density Change After Parathyroidectomy in Primary Hyperparathyroidism.
Burm SW; Hong N; Lee S; Kim GJ; Hwang SH; Jeong J; Rhee Y
J Clin Endocrinol Metab; 2022 May; 107(6):e2474-e2480. PubMed ID: 35148405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
